▲ +146.56% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Pulse Biosciences in the last 3 months. The average price target is $43.00, with a high forecast of $46.00 and a low forecast of $40.00. The average price target represents a 146.56% upside from the last price of $17.44.
The current consensus among 2 contributing investment analysts is to buy stock in Pulse Biosciences. This Buy consensus rating has held steady for over two years.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue primarily for dermatology applications by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.